top
Search terms
Results 1 - 10 of 18 - ordered by :
Pages: 1 2
Ehjournal

The Yentl Syndrome has drawn our attention to cardiovascular healthcare inequality between males and females and has prompted the deeper investigation of coronary artery disease (CAD) in women.1 As a ...

European Heart Journal, Gebhard, Catherine

Date : 07/04/2017 Item size : 163359 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/09/2015
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015 Item size : 220026 bytes
Ehjournal

Statins are a cornerstone of cardiovascular prevention and are highly recommended in current guidelines.1 However, statin-associated muscle symptoms are one of the principal reasons for statin ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/05/2015 Item size : 141183 bytes
Ehjournal

Statins are a cornerstone of cardiovascular prevention and are highly recommended in current guidelines.1 However, statin-associated muscle symptoms are one of the principal reasons for statin ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/05/2015 Item size : 166970 bytes
Ehjournal

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality See page 3531 for the editorial comment on this article (doi:10.1093/eurheartj/eht382) Introduction ...

European Heart Journal, Silbernagel, Guenther, Schöttker, Ben, Appelbaum, Sebastian, Scharnagl, Hubert, Kleber, Marcus E., Grammer, Tanja B., Ritsch, Andreas, Mons, Ute, Holleczek, Bernd, ...

Date : 07/12/2013
Ehjournal

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality See page 3531 for the editorial comment on this article (doi:10.1093/eurheartj/eht382) Introduction ...

European Heart Journal, Silbernagel, Guenther, Schöttker, Ben, Appelbaum, Sebastian, Scharnagl, Hubert, Kleber, Marcus E., Grammer, Tanja B., Ritsch, Andreas, Mons, Ute, Holleczek, Bernd, ...

Date : 07/12/2013
Ehjournal

Diabetic patients had higher C-reactive protein and MCP-1 levels vs. non-diabetic patients in OPUS-TIMI 16 (9 vs. 7.8 mg/L, P = 0.002, and 190.6 vs. 170.8 pg/mL, P = 0.04, respectively), higher ...

European Heart Journal, Ray, Kausik K., Cannon, Christopher P., Morrow, David A., Kirtane, Ajay J., Buros, Jacqueline, Rifai, Nader, McCabe, Carolyn H., Gibson, C. Michael, Braunwald, Eugene

Date : 01/04/2007
Ehjournal

Diabetic patients had higher C-reactive protein and MCP-1 levels vs. non-diabetic patients in OPUS-TIMI 16 (9 vs. 7.8 mg/L, P = 0.002, and 190.6 vs. 170.8 pg/mL, P = 0.04, respectively), higher ...

European Heart Journal, Ray, Kausik K., Cannon, Christopher P., Morrow, David A., Kirtane, Ajay J., Buros, Jacqueline, Rifai, Nader, McCabe, Carolyn H., Gibson, C. Michael, Braunwald, Eugene

Date : 01/04/2007 Item size : 266328 bytes